Case number 1:23-cv-01277
Eli Lilly and Company et al v. MSN Laboratories Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 17, 2024 | N/A | CASE CLOSED per D.I. 95 in Lead Case C.A. No. 22-1114. (ceg) (Entered: 05/17/2024) (0) |
| May 17, 2024 | 13 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,158,616 B2. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 05/17/2024) (0) |
| Jan 17, 2024 | 12 | SO ORDERED, re (61 in 1:22-cv-01114-JLH, 11 in 1:23-cv-01277-JLH) Stipulation and Order to Consolidate C.A. No. 23-1277-JLH with C.A. No. 22-1114-JLH. Signed by Judge Jennifer L. Hall on 1/17/2024. Associated Cases: 1:22-cv-01114-JLH, 1:23-cv-01277-JLH(ceg) (Entered: 01/17/2024) (3) |
| Jan 17, 2024 | N/A | Case associated with lead case: Create association to 1:22-cv-01114-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:22-cv-01114-JLH ONLY. (ceg) (Entered: 01/17/2024) (0) |
| Jan 12, 2024 | N/A | Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:22-cv-01114-JLH, 1:22-cv-01115-JLH, 1:23-cv-01277-JLH (rjb) (Entered: 01/12/2024) (0) |
| Jan 11, 2024 | 11 | STIPULATION and [Proposed] Order to Consolidate by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ekiner, Kaan) (Entered: 01/11/2024) (3) |
| Nov 15, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 11/15/2023) (0) |
| Nov 15, 2023 | 10 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 11/15/2023) (2) |
| Nov 14, 2023 | 8 | WAIVER OF SERVICE returned executed by Incyte Corporation, Eli Lilly and Company, Incyte Holdings Corporation: For MSN Pharmaceuticals Inc. waiver sent on 11/13/2023, answer due 1/12/2024. (Tigan, Jeremy) (Entered: 11/14/2023) (1) |
| Nov 14, 2023 | 9 | WAIVER OF SERVICE returned executed by Incyte Corporation, Eli Lilly and Company, Incyte Holdings Corporation: For MSN Laboratories Private Limited waiver sent on 11/13/2023, answer due 1/12/2024. (Tigan, Jeremy) (Entered: 11/14/2023) (1) |
| Nov 8, 2023 | 1 | Complaint* (1) |
| Nov 8, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 11/09/2023) (3) |
| Nov 8, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/4/2023. Date of Expiration of Patent: 6/8/2030.Thirty Month Stay Deadline: 4/4/2026. (mpb) (Entered: 11/09/2023) (1) |
| Nov 8, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,158,616 B2. (mpb) (Entered: 11/09/2023) (1) |
| Nov 8, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Eli Lilly and Company. (mpb) (Entered: 11/09/2023) (1) |
| Nov 8, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Incyte Corporation for Incyte Holdings Corporation filed by Incyte Corporation, Incyte Holdings Corporation. (mpb) (Entered: 11/09/2023) (1) |
| Nov 8, 2023 | 7 | Summons Issued as to MSN Laboratories Private Limited on 11/8/2023; MSN Pharmaceuticals Inc. on 11/8/2023. (Attachments: # 1 Summons Issued)(mpb) (Entered: 11/09/2023) (0) |
